Cross-clade protective immunity of H5N1 influenza vaccines in a mouse model
- 1 November 2008
- Vol. 26 (50) , 6398-6404
- https://doi.org/10.1016/j.vaccine.2008.08.053
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategiesProceedings of the National Academy of Sciences, 2008
- Strategies for developing vaccines against H5N1 influenza A virusesTrends in Molecular Medicine, 2006
- Live, Attenuated Influenza A H5N1 Candidate Vaccines Provide Broad Cross-Protection in Mice and FerretsPLoS Medicine, 2006
- Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trialThe Lancet, 2006
- Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) virusesVaccine, 2006
- Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trialThe Lancet, 2006
- The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolateVaccine, 2006
- Safety and Immunogenicity of an Inactivated Subvirion Influenza A (H5N1) VaccineNew England Journal of Medicine, 2006
- Establishment of multiple sublineages of H5N1 influenza virus in Asia: Implications for pandemic controlProceedings of the National Academy of Sciences, 2006
- Generation of influenza A viruses entirely from cloned cDNAsProceedings of the National Academy of Sciences, 1999